hDMT highlighted in Year Review 2018 of Top Sector LSH

Thursday, 14 February 2019

In the Year in Review 2018 published by the Top Sector Life Sciences & Health, named Health~Holland, hDMT is highlighted as one of the four strategic public-private partnerships they support during their fundamental, industrial and experimental R&D.

Screenshot Year in Review Health~Holland

[Text below comes from the Year Review]

human organ and Disease Model Technologies (hDMT)

With 3D technology toward personalised treatment for present and next generations.

The new European Organ-on-Chip Society (EUROoCS) was officially launched in November 2018. The purpose of the society is to encourage and develop Organ-on-Chip (OoC) research, and to provide opportunities to share and advance knowledge and expertise in this field.

The Dutch human organ and disease model technologies (hDMT) consortium aims to develop innovative 3D human organ and disease models on chips that recapitulate healthy and diseased human tissue. Furthermore, they want to enable valorisation and stimulate implementation of these models as test systems for different purposes.

hDMT and Top Sector LSH joined forces in a new call, named Health~Holland Organ-on-Chip Showcases, to stimulate the early phase in OoC technology development. After building a strong national platform and attracting substantial financial funding for R&D, hDMT expanded to a European level last autumn. The EUROoCS is one of the first outcomes of the Horizon 2020 project ORCHID (Organ-on-Chip In Development), which aims to create a roadmap for Organ-on-Chip technology and to build a network of all parties involved.

Back to the news overview